AI, licensing and remote prescribing among key issues facing telepsychiatry

The U.S. Drug Enforcement Administration’s stance on prescribing via telehealth has been evolving, with hints toward an appetite for lasting flexibilities. This, among other policy shifts, has a direct impact on healthcare provider organizations and telemedicine companies delivering care…

Source: Healthcareitnews.com and Read More